Insider screener

Period: 12 months Role: Other officers × Plan: Scheduled (10b5-1) × + Add filter Clear all
Saved screens

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

10,539 decisions over 12 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

10,539 decisions over 12 months Remove this filter
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

10,539 decisions over 12 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

10,539 decisions over 12 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
10,539 decisions over 12 months Remove this filter
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
10,539 decisions over 12 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

10,539 decisions over 12 months
Stock
Insider
Type ?
Why it stands out
4 Nov 2025
Howard Justyn Russell Executive Chair · indirect
Sold on a plan
$204.36K 20,000 at 10.22
72.9%
Sold half or more
4 Nov 2025
MAETZOLD DEREK J Pres. & Chief Exec. Officer
Sold on a plan 2×
$203.78K 6,695 at 30.44
10.6%
Planned (10b5-1)
4 Nov 2025
OHAYER MATTHEW EXECUTIVE CHAIRPERSON
Sold on a plan
$188.90K 5,000 at 37.78
0.1%
Planned (10b5-1)
4 Nov 2025
Hasson Heather L. Executive Chair
Sold on a plan
$172.53K 23,356 at 7.39
1.8%
Planned (10b5-1)
4 Nov 2025
Mehta Satish Chief Technology Officer
Sold on a plan
$151.56K 4,642 at 32.65
2.0%
Planned (10b5-1)
4 Nov 2025
Malik Fady Ibraham EVP Research & Development
Sold on a plan
$136.67K 2,295 at 59.55
1.6%
Planned (10b5-1)
4 Nov 2025
Indelicarto Thomas C EVP, Gen Counsel & Secretary
Sold on a plan
$81.67K 334 at 244.52
1.0%
Planned (10b5-1)
4 Nov 2025
McGrane Ashley General Counsel and Corp Sec
Sold on a plan
$77.14K 6,600 at 11.69
18.9%
Planned (10b5-1)
4 Nov 2025
Denton Sheila A. EVP & General Counsel
Sold on a plan
$60.61K 598 at 101.36
2.2%
Planned (10b5-1)
4 Nov 2025
Moreadith Randall Chief Scientific Officer
Sold on a plan
$13.63K 3,102 at 4.40
100%
Sold half or more
4 Nov 2025
Harrison Robert Gardner Chief Information Officer
Sold on a plan
$6.14K 2,000 at 3.07
2.0%
Planned (10b5-1)
3 Nov 2025
Klarich Lee EVP Chief Product & Tech Ofcr
Sold on a plan 6×
$26.32M 120,774 at 217.94
25.3%
Planned (10b5-1)
3 Nov 2025
BENKOWITZ MICHAEL PRESIDENT AND COO · indirect
Sold on a plan 11×
$9.66M 22,500 at 429.25
100%
Sold half or more
3 Nov 2025
Smith Michael Alexander Chief Legal Officer
Sold on a plan 8×
$4.99M 27,130 at 183.78
33.1%
Planned (10b5-1)
3 Nov 2025
Fitzgerald Joseph Michael EVP & Group Pres, Cardiology
Sold on a plan 3×
$4.97M 50,000 at 99.47
21.9%
Planned (10b5-1)
3 Nov 2025
MONDELLO MARK T Executive Chairman
Sold on a plan 6×
$4.42M 20,000 at 220.83
1.6%
Planned (10b5-1)
3 Nov 2025
Venturo Brian M Chief Strategy Officer · indirect
Sold on a plan 14×
$3.83M 29,916 at 127.94
12.2%
Planned (10b5-1)
3 Nov 2025
Gallagher Daniel Martin Jr Chief Legal Officer
Sold on a plan 7×
$3.65M 25,000 at 145.95
4.4%
Planned (10b5-1)
3 Nov 2025
Rabinowitz Matthew EXECUTIVE CHAIRMAN
Sold on a plan
$3.42M 17,100 at 200.00
0.7%
Planned (10b5-1)
3 Nov 2025
HUSTON BENJAMIN E. Chief Operating Officer
Sold on a plan 24×
$3.25M 10,000 at 324.57
8.9%
Planned (10b5-1)
3 Nov 2025
Kleinerman Christian EVP, Product Management
Sold on a plan
$2.78M 10,000 at 277.73
1.9%
Planned (10b5-1)
3 Nov 2025
WHALEN CHAD MICHAEL EVP, Worldwide Sales
Sold on a plan 5×
$2.36M 9,436 at 249.77
26.9%
Planned (10b5-1)
3 Nov 2025
FOUNTAIN THOMAS DEAN EVP Global Services & Strategy
Sold on a plan 5×
$2.08M 8,318 at 249.78
27.0%
Planned (10b5-1)
3 Nov 2025
Mansueto Joseph D Executive Chairman
Sold on a plan 3×
$1.54M 7,250 at 211.95
0.1%
Planned (10b5-1)
3 Nov 2025
Maduck Sean See Remarks
Sold on a plan
$1.48M 20,000 at 73.99
71.7%
Sold half or more
3 Nov 2025
Boyd William M III Chief Strategy Officer
Sold on a plan 4×
$963.30K 11,735 at 82.09
30.5%
Planned (10b5-1)
3 Nov 2025
Howse Curtis See remarks
Sold on a plan
$894.61K 12,086 at 74.02
10.0%
Planned (10b5-1)
3 Nov 2025
Miosi Salvatore A President & COO
Sold on a plan
$825.60K 30,000 at 27.52
15.8%
Planned (10b5-1)
3 Nov 2025
OHAYER MATTHEW EXECUTIVE CHAIRPERSON
Sold on a plan 2×
$798.05K 25,000 at 31.92
0.4%
Planned (10b5-1)
3 Nov 2025
Kramer Douglas James Chief Legal Officer
Sold on a plan 3×
$766.60K 3,000 at 255.53
2.3%
Planned (10b5-1)
3 Nov 2025
Phillips Dominic SEE REMARKS
Sold on a plan 2×
$741.10K 18,348 at 40.39
2.6%
Planned (10b5-1)
3 Nov 2025
Buckley Merilee CHIEF ACCOUNTING OFFICER
Sold on a plan 2×
$727.00K 11,827 at 61.47
100%
Sold half or more
3 Nov 2025
Mullen John P President
Sold on a plan
$695.55K 3,000 at 231.85
1.9%
Planned (10b5-1)
3 Nov 2025
Kaufman Matthew D Chief Safety Officer
Sold on a plan
$677.94K 6,000 at 112.99
2.2%
Planned (10b5-1)
3 Nov 2025
Kidd Mark EVP, GM Data Centers & ALM
Sold on a plan
$615.06K 6,000 at 102.51
8.2%
Planned (10b5-1)
3 Nov 2025
Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS
Sold on a plan 3×
$595.81K 3,000 at 198.60
2.6%
Planned (10b5-1)
3 Nov 2025
Gong Xunkai Executive Chairman · indirect
Sold on a plan
$581.84K 41,679 at 13.96
0.3%
Planned (10b5-1)
3 Nov 2025
STETZ MATTIAS Chief Operating Officer
Sold on a plan
$512.69K 30,000 at 17.09
13.3%
Planned (10b5-1)
3 Nov 2025
Green Anthony C Chief Corporate Officer, CLO
Sold on a plan
$475.85K 22,499 at 21.15
11.2%
Planned (10b5-1)
3 Nov 2025
Fukushima Ryan Chief Operating Officer · indirect
Sold on a plan 3×
$445.16K 5,000 at 89.03
3.8%
Planned (10b5-1)
3 Nov 2025
Murphy Patrick Joseph Co-Chief Operating Officer
Sold on a plan
$379.90K 290 at 1,310.00
21.6%
Planned (10b5-1)
3 Nov 2025
Zimmerman Gregory E EVP & Chief Investment Officer · indirect
Sold on a plan
$369.10K 7,500 at 49.21
9.2%
Planned (10b5-1)
3 Nov 2025
Lyon Joseph Douglas See Remarks
Sold on a plan
$368.24K 5,000 at 73.65
32.7%
Planned (10b5-1)
3 Nov 2025
Zales Samuel COO and President
Sold on a plan
$349.80K 10,000 at 34.98
2.4%
Planned (10b5-1)
3 Nov 2025
Cunningham Paul Sr. Vice President
Sold on a plan
$340.26K 1,000 at 340.26
1.0%
Planned (10b5-1)
3 Nov 2025
Olivan Javier Chief Operating Officer
Sold on a plan
$339.15K 517 at 656.00
6.5%
Planned (10b5-1)
3 Nov 2025
Xie Michael VP, ENGINEERING & CTO
Sold on a plan 3×
$306.82K 3,546 at 86.53
0.0%
Planned (10b5-1)
3 Nov 2025
Palmer Stephen R Vice President of Accounting
Sold on a plan
$305.00K 1,000 at 305.00
2.3%
Planned (10b5-1)
3 Nov 2025
Heeson Lee EVP, Head of Incyte Intl
Sold on a plan
$289.02K 3,074 at 94.02
9.5%
Planned (10b5-1)
3 Nov 2025
Watanabe Todd See Remarks
Sold on a plan 2×
$285.40K 11,547 at 24.72
1.4%
Planned (10b5-1)
Showing 10,451–10,500 of 10,539. ← Newer Page 210 of 211 Older →